Tolly G. Epstein

AAAAI/ACAAI Surveillance Study of Subcutaneous Immunotherapy, Years 2008-2012: An Update on Fatal and Nonfatal Systemic Allergic Reactions

Tolly G. Epstein, Gary M. Liss, Karen Murphy-Berendts et al. · The Journal of Allergy and Clinical Immunology In Practice · 2014 · 137 citations

Asthma, Allergy, Autoimmune Disease +13

Risk factors for fatal and nonfatal reactions to subcutaneous immunotherapy

Tolly G. Epstein, Gary M. Liss, Karen Murphy-Berendts et al. · Annals of Allergy Asthma & Immunology · 2016 · 114 citations

Vaccination, Autoimmune Disease, Allergy +7

AAAAI/ACAAI Subcutaneous Immunotherapy Surveillance Study (2013-2017): Fatalities, Infections, Delayed Reactions, and Use of Epinephrine Autoinjectors

Tolly G. Epstein, Gary M. Liss, Karen Berendts et al. · The Journal of Allergy and Clinical Immunology In Practice · 2019 · 88 citations

Autoimmune Disease, Allergy, Immunodeficiencies +8

AAAAI and ACAAI surveillance study of subcutaneous immunotherapy, Year 3: what practices modify the risk of systemic reactions?

Tolly G. Epstein, Gary M. Liss, Karen Murphy-Berendts et al. · Annals of Allergy Asthma & Immunology · 2013 · 87 citations

Autoimmune Disease, Allergy, Clinical Epidemiology +8

Immediate and delayed-onset systemic reactions after subcutaneous immunotherapy injections: ACAAI/AAAAI surveillance study of subcutaneous immunotherapy–year 2

Tolly G. Epstein, Gary M. Liss, Karen Murphy-Berendts et al. · Annals of Allergy Asthma & Immunology · 2011 · 72 citations · Full text

Autoimmune Disease, Allergy, Immunodeficiencies +9